Introduction: To compare a schedule with cyclic withdrawal (CW) of interferon beta (IFN-b) 1b, respect to the full regimen (FR), in relapsing-remitting MS (RR-MS). This evidence concerns the gene IFNB1 and relapsing-remitting multiple sclerosis.